Barclays On Merck: Too Much Underlying Value To Ignore By: Benzinga via Benzinga December 01, 2015 at 07:36 AM EST Merck & Co., Inc. (NYSE: MRK) shares are down 13 percent in the last six months, having plunged in August and September and ... Read More >> Related Stocks: Merck & Co Pfizer